107 related articles for article (PubMed ID: 20976000)
21. Precancerous lesions of cervix among women infected with HIV in Referral Hospitals of Amhara Region, Northwest Ethiopia: a cross sectional study.
Kassa LS; Dile WM; Zenebe GK; Berta AM
Afr Health Sci; 2019 Mar; 19(1):1695-1704. PubMed ID: 31149000
[TBL] [Abstract][Full Text] [Related]
22. Methylation of High-Risk Human Papillomavirus Genomes Are Associated with Cervical Precancer in HIV-Positive Women.
Gradissimo A; Lam J; Attonito JD; Palefsky J; Massad LS; Xie X; Eltoum IE; Rahangdale L; Fischl MA; Anastos K; Minkoff H; Xue X; D'Souza G; Flowers LC; Colie C; Shrestha S; Hessol NA; Strickler HD; Burk RD
Cancer Epidemiol Biomarkers Prev; 2018 Dec; 27(12):1407-1415. PubMed ID: 30237251
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for cervical precancer detection among previously unscreened HIV-infected women in Western Kenya.
Huchko MJ; Leslie H; Sneden J; Maloba M; Abdulrahim N; Bukusi EA; Cohen CR
Int J Cancer; 2014 Feb; 134(3):740-5. PubMed ID: 23900762
[TBL] [Abstract][Full Text] [Related]
24. HPV Types in Cervical Precancer by HIV Status and Birth Region: A Population-Based Register Study.
Carlander C; Lagheden C; Eklund C; Nordqvist Kleppe S; Dzabic M; Wagner P; Yilmaz A; Elfgren K; Sönnerborg A; Sparén P; Dillner J
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2662-2668. PubMed ID: 32967862
[TBL] [Abstract][Full Text] [Related]
25. Precancerous Cervical Lesion Among HIV-Positive Women in Sub-Saharan Africa: A Systematic Review and Meta-Analysis.
Weldegebreal F; Worku T
Cancer Control; 2019; 26(1):1073274819845872. PubMed ID: 31043067
[TBL] [Abstract][Full Text] [Related]
26. Cervical Intraepithelial Neoplasia Grade 3 (CIN3) in Women Younger than 30 Years Was Significantly Associated with HPV16/18 Genotypes.
Bruno MT; Panella MM; Valenti G; Ruggeri Z; Sgalambro F; Reina S; Mereu L
Cancers (Basel); 2024 May; 16(11):. PubMed ID: 38893161
[TBL] [Abstract][Full Text] [Related]
27. Lymphocyte Subsets in Cervicovaginal Lavage Specimens of HIV-Infected Women: A Surrogate Risk Marker of HPV-Associated Cervical Lesions.
Brito MJ; Quintas A; Passos F; Alves AT; Félix A; Martins CG
Pathobiology; 2023; 90(3):176-186. PubMed ID: 36302344
[TBL] [Abstract][Full Text] [Related]
28. HPV types, HIV and invasive cervical carcinoma risk in Kampala, Uganda: a case-control study.
Odida M; Sandin S; Mirembe F; Kleter B; Quint W; Weiderpass E
Infect Agent Cancer; 2011 Jun; 6(1):8. PubMed ID: 21702999
[TBL] [Abstract][Full Text] [Related]
29. Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study.
Abraham AG; D'Souza G; Jing Y; Gange SJ; Sterling TR; Silverberg MJ; Saag MS; Rourke SB; Rachlis A; Napravnik S; Moore RD; Klein MB; Kitahata MM; Kirk GD; Hogg RS; Hessol NA; Goedert JJ; Gill MJ; Gebo KA; Eron JJ; Engels EA; Dubrow R; Crane HM; Brooks JT; Bosch RJ; Strickler HD;
J Acquir Immune Defic Syndr; 2013 Apr; 62(4):405-13. PubMed ID: 23254153
[TBL] [Abstract][Full Text] [Related]
30. Incidence and progression of cervical lesions in women with HIV: a systematic global review.
Denslow SA; Rositch AF; Firnhaber C; Ting J; Smith JS
Int J STD AIDS; 2014 Mar; 25(3):163-77. PubMed ID: 24216030
[TBL] [Abstract][Full Text] [Related]
31. Precancerous cervical lesion and associated factors among HIV-infected women in Ethiopia: systematic review and meta- analysis.
Ferede YA; Tassew WC; Zeleke AM
BMC Cancer; 2024 Jun; 24(1):678. PubMed ID: 38831404
[TBL] [Abstract][Full Text] [Related]
32. Trend of HPV 16/18 Genotypes in Cervical Intraepithelial Neoplasia Grade 3: Data for 2007-2018.
Giannella L; Delli Carpini G; Di Giuseppe J; Bogani G; Gardella B; Monti E; Liverani CA; Ghelardi A; Insinga S; Montanari M; Raspagliesi F; Spinillo A; Vercellini P; Roncella E; Ciavattini A
Infect Drug Resist; 2021; 14():3763-3771. PubMed ID: 34557001
[TBL] [Abstract][Full Text] [Related]
33. Over-reported peripheral neuropathy symptoms in a cohort of HIV infected and uninfected Rwandan women: the need for validated locally appropriate questionnaires.
Tumusiime DK; Musabeyezu E; Mutimurah E; Hoover DR; Shi Q; Rudakemwa E; Ndacyayisenga V; Dusingize JC; Sinayobye JD; Stewart A; Venter FW; Anastos K
Afr Health Sci; 2014 Jun; 14(2):460-7. PubMed ID: 25320598
[TBL] [Abstract][Full Text] [Related]
34. Changes in the Proteome in the Development of Chronic Human Papillomavirus Infection-A Prospective Study in HIV Positive and HIV Negative Rwandan Women.
Bienvenu E; Mukanyangezi MF; Rulisa S; Martner A; Hasséus B; Vorontsov E; Tobin G; Giglio D
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885095
[TBL] [Abstract][Full Text] [Related]
35. Long-term follow-up on HIV infected and non-infected women with cervical cancer from Tanzania: staging, access to cancer-directed therapies and associated survival in a real-life remote setting.
Glasmeyer L; Mcharo RD; Torres L; Lennemann T; Danstan E; Mwinuka N; Judick M; Mueller W; Mbuya W; Hölscher M; Lellé R; Geldmacher C; Kroidl A; France JR
BMC Cancer; 2022 Aug; 22(1):892. PubMed ID: 35971100
[TBL] [Abstract][Full Text] [Related]
36. HIV serostatus and tumor differentiation among patients with cervical cancer at Bugando Medical Centre.
Matovelo D; Magoma M; Rambau P; Massinde A; Masalu N
BMC Res Notes; 2012 Aug; 5():406. PubMed ID: 22862747
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and genotypes of human papilloma virus infection in CIN3 in Beijing, China.
Zhao XY; Kong WM; Jiao SM; Song D; Chen J; Shang RT
Transl Cancer Res; 2020 Mar; 9(3):1978-1984. PubMed ID: 35117544
[TBL] [Abstract][Full Text] [Related]
38. Inhibited interpersonal coping style predicts poorer adherence to scheduled clinic visits in human immunodeficiency virus infected women at risk for cervical cancer.
Pereira DB; Antoni MH; Danielson A; Simon T; Efantis-Potter J; O'Sullivan MJ
Ann Behav Med; 2004 Dec; 28(3):195-202. PubMed ID: 15576258
[TBL] [Abstract][Full Text] [Related]
39. Assessment of haematological parameters in HIV-infected and uninfected Rwandan women: a cross-sectional study.
Munyazesa E; Emile I; Mutimura E; Hoover DR; Shi Q; McGinn AP; Musiime S; Muhairwe F; Rutagengwa A; Dusingize JC; Anastos K
BMJ Open; 2012; 2(6):. PubMed ID: 23169875
[TBL] [Abstract][Full Text] [Related]
40. HPV16 variant lineage, clinical stage, and survival in women with invasive cervical cancer.
Zuna RE; Tuller E; Wentzensen N; Mathews C; Allen RA; Shanesmith R; Dunn ST; Gold MA; Wang SS; Walker J; Schiffman M
Infect Agent Cancer; 2011 Oct; 6():19. PubMed ID: 22035468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
